Overview
A naturally occurring glucocorticoid. It has been used in replacement therapy for adrenal insufficiency and as an anti-inflammatory agent. Cortisone itself is inactive. It is converted in the liver to the active metabolite hydrocortisone. (From Martindale, The Extra Pharmacopoeia, 30th ed, p726)
Indication
肾上腺皮质激素类药。主要用于肾上腺皮质功能减退症及垂体功能减退症的替代治疗,亦可用于过敏性和炎症性疾病;局部外用于治疗虹膜睫状体炎、虹膜炎、角膜炎、过敏性结膜炎等。也可用于治疗角膜移植后的排斥反应和眼科手术后的炎症反应。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2023/10/13 | Not Applicable | Completed | |||
2018/11/30 | Phase 4 | UNKNOWN | Federico II University | ||
2018/07/09 | Phase 2 | Completed | |||
2016/09/28 | Not Applicable | Completed | |||
2016/08/04 | Not Applicable | Completed | |||
2015/12/24 | Phase 4 | Completed | Scott and White Hospital & Clinic | ||
2014/07/21 | Not Applicable | Recruiting | |||
2014/03/19 | N/A | Completed | Northern Orthopaedic Division, Denmark | ||
2011/10/06 | Phase 3 | UNKNOWN | Federal University of São Paulo | ||
2010/06/30 | Phase 2 | Completed | Technical University of Munich |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Cortisone Acetate Tablets | 国药准字H51022117 | 化学药品 | 片剂 | 6/28/2020 | |
Cortisone Acetate Tablets | 国药准字H61022391 | 化学药品 | 片剂 | 12/11/2020 | |
Cortisone Acetate Tablets | 国药准字H51022118 | 化学药品 | 片剂 | 6/28/2020 | |
Cortisone Acetate Tablets | 国药准字H42021565 | 化学药品 | 片剂 | 7/4/2022 | |
Cortisone Acetate Tablets | 国药准字H37023482 | 化学药品 | 片剂 | 3/12/2020 | |
Cortisone Acetate Tablets | 国药准字H37022909 | 化学药品 | 片剂 | 3/12/2020 | |
Cortisone Acetate Tablets | 国药准字H37022908 | 化学药品 | 片剂 | 3/12/2020 | |
Cortisone Acetate Tablets | 国药准字H11020508 | 化学药品 | 片剂 | 12/8/2020 | |
Cortisone Acetate Tablets | 国药准字H31022270 | 化学药品 | 片剂 | 2/18/2024 | |
Cortisone Acetate Eye Ointment | 国药准字H53020442 | 化学药品 | 眼用制剂 | 6/15/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.